Bunkerhill Health receives FDA clearance for an AI model that detects mitral annular calcification (MAC) on routine, non-gated CT scans.
Key Details
- 1Bunkerhill Health’s AI model (Bunkerhill MAC) is FDA-cleared to detect and evaluate MAC.
- 2The tool works on routine, non-gated CT scans, expanding accessibility for cardiovascular risk detection.
- 3This is the first FDA-approved AI specifically for MAC identification.
- 4Development included data from over 25 academic medical centers, including Stanford University.
- 5The algorithm is integrated into Carebricks, Bunkerhill Health’s generative AI platform.
Why It Matters
This clearance introduces a new, scalable AI solution to consistently identify a cardiovascular risk marker that can be missed in routine practice, potentially improving patient care and research. Automating MAC detection could significantly impact cardiovascular and structural heart disease assessments in radiology workflows.
Source
Cardiovascular Business
Related News
•Radiology Business
Medicare Grants Add-On Payment for Aidoc's AI CT Body Triage Tool
Medicare has approved new inpatient add-on payments for Aidoc's AI-powered CT Body Triage tool, supporting hospitals' adoption of this technology.
•Radiology Business
Clinical Expertise Shields Radiologists from LLM Errors, Study Finds
Radiologist expertise and AI model confidence are key to avoiding errors from large language models in imaging interpretation.
•Radiology Business
Deep Learning Enhances Prediction of Incidental Lung Nodule Malignancy
Deep learning models outperformed traditional tools in predicting malignancy of incidental lung nodules using diverse imaging datasets.